BOCA RATON, Fla., July 31, 2019 /PRNewswire/ -- Peroxfarma, a leading European pharmaceutical company, is bringing an "extra dose of health" to America.Peroxfarma, which decided this year to expand its retail distribution to the United States, offers a wide array of nutritional supplements, such as Epaplus Arthicare, Epaplus S

SLOUGH, England and RICHMOND, Va., July 31, 2019 /PRNewswire/ -- Indivior PLC (LON: INDV) today announced that its first half 2019 results press release and investor supplement are now available via the London Stock Exchange's Regulatory News Service (RNS) and on the "Investors" section of the company's website at

LUND, Sweden, July 31, 2019  /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX), today announces that it has regained exclusive, worldwide rights from Janssen Biotech Inc. to develop and commercialize the CD40 agonistic antibody, ADC-1013 (JNJ-64457107), its lead tumor-directed immunotherapy candidate, in Phase I development for the treatme

ITASCA, Ill., July 31, 2019 /PRNewswire/ -- In recognition of National Heatstroke Prevention Day on July 31, the National Safety Council and the National High

WHIPPANY, N.J., July 30, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) today approved Nubeqa® (darolutamide), an androgen receptor inhibitor (ARi), for the treatment of patients with non-metastatic castration-resistant prostate cancer (nmCRPC).1 The FDA approval is based on the Phase III ARAMIS trial evaluating Nubeqa plu

SEOUL, Korea, July 30, 2019 /PRNewswire/ -- Mezzion Pharma Co. Ltd. today announced that top line data from the Phase 3 FUEL trial, which was designed to evaluate the safety and efficacy of udenafil for the treatment of certain adolescents with congenital single ventricle heart disease (SVHD), had positive results for key parameters. Although Mez

NEW YORK, July 30, 2019 /PRNewswire/ -- Clayton, Dubilier & Rice today completed the sale of TRANZACT, a leading provider of comprehensive direct-to-consumer sales and marketing solutions for individual Medicare and Life insurance policies across the US, to Willis Towers Watson (NASDAQ: WLTW). The total purchase price was $1.3 billion

GREENWOOD VILLAGE, Colo., July 30, 2019 /PRNewswire/ -- Bellco Credit Union presented a grant of $100,000 to Children's Hospital Colorado (Children's Colorado) Resiliency Initiatives, which provide support for hospital staff caring for ill or injured children. The Resiliency Initiatives aim to bui

TORONTO, July 30, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a medical cannabis company with core operations in Latin America, reports that the Company has received final approval from the TSX Venture Exchange ("TSXV

PHOENIX, July 30, 2019 /PRNewswire/ -- 4Front Holdings LLC ("4Front") is pleased to provide an operational update on Mission, its branded network of cannabis dispensaries.